Description
| Product Name | CAT.No | Size |
| Anti-HBc | BXE0761A | 96T |
| Anti-HBc | BXE0761C | 480T |
| Anti-HBe | BXE0772A | 96T |
| Anti-HBs (Quantitative) | BXE0752A | 96T |
| Anti-HBs (Quantitative) | BXE0752C | 480T |
| Hbc.IgM | BXE0603A | 96T |
| HbeAg | BXE0771A | 96T |
| HbsAg | BXE0741A | 96T |
| HbsAg | BXE0741C | 480T |
| HbsAg (High Sensitivity) | BXE0742A | 96T |
| HbsAg (High Sensitivity) | BXE0742C | 480T |
| HBsAg HS (With CE) | BXE0743A | 96T |
| HBsAg HS (With CE) | BXE0743C | 480T |
Product Description
The Biorex Diagnostics Hepatitis B Virus (HBV) ELISA kits are highly sensitive and specific microplate enzyme-linked immunosorbent assays (ELISA) designed for the quantitative measurement of HBV antibodies in human serum or plasma. Hepatitis B is a bloodborne viral infection caused by a double-stranded DNA virus of the Hepadnaviridae family, representing a significant global health burden. Transmission occurs primarily through blood, sexual contact, needle sharing, transfusions, and vertical transmission from mother to child. Chronic infection can lead to serious liver conditions, including cirrhosis, liver failure, and hepatocellular carcinoma, making early and accurate detection essential for patient care and public health.
Key Features
- Quantitative Microplate ELISA – provides precise and reliable measurement of HBV antibodies.
- High Sensitivity and Specificity – ensures accurate identification of current or past infection.
- Serum and Plasma Compatibility – validated for routine clinical and laboratory testing.
- Reproducible Results – delivers consistent performance across multiple assays and runs.
- Comprehensive Kit Components – includes ready-to-use reagents, controls, and standards for streamlined workflows.
- Versatile Applications – suitable for clinical diagnostics, patient management, blood screening, and epidemiological research.
The Biorex Diagnostics HBV ELISA kits provide a trusted, efficient, and clinically relevant solution for laboratories and healthcare providers worldwide. By enabling accurate detection and quantification of HBV antibodies, these assays support the diagnosis, monitoring, and management of hepatitis B infection. They are ideal for evaluating immune response, assessing disease progression, guiding treatment decisions, and preventing transmission through blood and organ screening programs. In addition, the kits facilitate research studies on viral hepatitis, vaccine efficacy, and liver disease epidemiology, contributing to improved clinical outcomes and enhanced public health initiatives. With reliable performance, ease of use, and robust clinical utility, the Biorex HBV ELISA kits are essential tools for accurate hepatitis B detection and comprehensive patient care.
Contact Us for more information.